| Primary |
| Induction Of Anaesthesia |
20.4% |
| Anaesthesia |
15.6% |
| Maintenance Of Anaesthesia |
8.8% |
| General Anaesthesia |
7.5% |
| Muscle Relaxant Therapy |
5.9% |
| Neuromuscular Blocking Therapy |
4.8% |
| Surgery |
4.8% |
| Hypothermia |
4.6% |
| Anaesthesia Procedure |
3.3% |
| Endotracheal Intubation |
2.9% |
| Hypotonia |
2.9% |
| Drug Use For Unknown Indication |
2.6% |
| Arrhythmia |
2.4% |
| Cardio-respiratory Arrest |
2.4% |
| Induction And Maintenance Of Anaesthesia |
2.4% |
| Intubation |
2.2% |
| Sedation |
2.0% |
| Lenticular Operation |
1.8% |
| Convulsion |
1.3% |
| Product Used For Unknown Indication |
1.3% |
|
| Drug Ineffective |
28.4% |
| Procedural Complication |
6.4% |
| Anaphylactic Reaction |
5.7% |
| Wrong Drug Administered |
5.7% |
| Ventricular Fibrillation |
5.0% |
| Anaphylactic Shock |
4.3% |
| Drug Effect Decreased |
3.5% |
| Endotracheal Intubation Complication |
3.5% |
| Hypotonia |
3.5% |
| Medication Error |
3.5% |
| Respiratory Depression |
3.5% |
| Trismus |
3.5% |
| Ventricular Tachycardia |
3.5% |
| Anaphylactoid Reaction |
2.8% |
| Electrocardiogram Qt Prolonged |
2.8% |
| Hyperthermia Malignant |
2.8% |
| Rhabdomyolysis |
2.8% |
| Sinus Tachycardia |
2.8% |
| Tachycardia |
2.8% |
| Ventricular Extrasystoles |
2.8% |
|
| Secondary |
| Anaesthesia |
37.3% |
| General Anaesthesia |
12.3% |
| Drug Use For Unknown Indication |
10.3% |
| Induction Of Anaesthesia |
8.1% |
| Maintenance Of Anaesthesia |
4.7% |
| Sedation |
3.4% |
| Surgery |
3.4% |
| Product Used For Unknown Indication |
3.0% |
| Anaesthesia Procedure |
2.3% |
| Hypotension |
1.9% |
| Hypertension |
1.7% |
| Anaesthesia Reversal |
1.5% |
| Hypotonia |
1.5% |
| Antibiotic Therapy |
1.4% |
| Muscle Relaxant Therapy |
1.4% |
| Premedication |
1.4% |
| Anaesthetic Premedication |
1.3% |
| Vitamin Supplementation |
1.1% |
| Diuretic Therapy |
1.0% |
| Neuromuscular Blockade Reversal |
0.9% |
|
| Cognitive Disorder |
19.4% |
| Dementia Alzheimer's Type |
8.4% |
| Rhabdomyolysis |
8.4% |
| Toxic Epidermal Necrolysis |
7.7% |
| Ventricular Fibrillation |
7.7% |
| Obstructive Airways Disorder |
5.2% |
| Tachypnoea |
4.5% |
| Urticaria |
4.5% |
| Ventricular Tachycardia |
4.5% |
| Bradycardia |
3.2% |
| Cardiac Arrest |
3.2% |
| Hypotension |
3.2% |
| Extrasystoles |
2.6% |
| Loss Of Consciousness |
2.6% |
| Medication Error |
2.6% |
| Proteinuria |
2.6% |
| Respiratory Depression |
2.6% |
| Tachycardia |
2.6% |
| Tryptase Increased |
2.6% |
| Anaphylactic Reaction |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.3% |
| Drug Use For Unknown Indication |
15.5% |
| Induction Of Anaesthesia |
10.8% |
| Maintenance Of Anaesthesia |
8.7% |
| Anaesthesia |
6.8% |
| General Anaesthesia |
3.4% |
| Sedation |
2.9% |
| Coronary Artery Bypass |
2.5% |
| Hypertension |
2.2% |
| Premedication |
2.1% |
| Pain |
1.6% |
| Prophylaxis |
1.4% |
| Induction And Maintenance Of Anaesthesia |
1.3% |
| Multiple Myeloma |
1.2% |
| Epidural Anaesthesia |
1.2% |
| Muscle Relaxant Therapy |
1.1% |
| Anaesthetic Premedication |
1.1% |
| Hypotonia |
1.1% |
| Antibiotic Prophylaxis |
0.9% |
| Neuromuscular Blockade Reversal |
0.8% |
|
| Ventricular Tachycardia |
8.7% |
| Injury |
7.6% |
| Pain |
6.7% |
| Ventricular Fibrillation |
6.4% |
| Cardiac Arrest |
5.8% |
| Hypotension |
5.5% |
| Renal Failure |
5.2% |
| Fear |
5.0% |
| Anxiety |
4.7% |
| Rhabdomyolysis |
4.7% |
| Tachycardia |
4.7% |
| Wound Haemorrhage |
4.7% |
| Arteriospasm Coronary |
4.1% |
| Sepsis |
4.1% |
| Anhedonia |
3.8% |
| Pulmonary Oedema |
3.8% |
| Respiratory Failure |
3.8% |
| Serotonin Syndrome |
3.8% |
| Oxygen Saturation Decreased |
3.5% |
| Stress |
3.5% |
|
| Interacting |
| Induction Of Anaesthesia |
15.1% |
| Product Used For Unknown Indication |
11.0% |
| Hypertension |
9.6% |
| Anaesthesia |
8.2% |
| Convulsion |
8.2% |
| Maintenance Of Anaesthesia |
8.2% |
| Tachycardia |
8.2% |
| General Anaesthesia |
6.8% |
| Blood Pressure Fluctuation |
4.1% |
| Epilepsy |
4.1% |
| Pneumonia |
4.1% |
| Sedation |
4.1% |
| Bronchospasm |
2.7% |
| Cardiovascular Event Prophylaxis |
1.4% |
| Hypothyroidism |
1.4% |
| Hypotonia |
1.4% |
| Muscle Relaxant Therapy |
1.4% |
|
| Drug Interaction |
30.8% |
| Cardiac Arrest |
15.4% |
| Neuromuscular Block Prolonged |
15.4% |
| Arrhythmia |
7.7% |
| Drug Effect Decreased |
7.7% |
| Drug Level Increased |
7.7% |
| Myopathy |
7.7% |
| Respiratory Depression |
7.7% |
|
